Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine

NCT01867463 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

230

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: Pfs25-EPA/Alhydrogel
BIOLOGICAL: Euvax B
BIOLOGICAL: Menactra

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]